J Jansen

1.9k total citations
65 papers, 1.5k citations indexed

About

J Jansen is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, J Jansen has authored 65 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 29 papers in Hematology and 18 papers in Genetics. Recurrent topics in J Jansen's work include Hematopoietic Stem Cell Transplantation (19 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). J Jansen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Immunodeficiency and Autoimmune Disorders (13 papers). J Jansen collaborates with scholars based in Netherlands, United States and Ukraine. J Jansen's co-authors include Hanneke C. Kluin‐Nelemans, Roel Willemze, Tucker W. LeBien, H. R. E. Schuit, WE Fibbe, JH Kersey, W. Hijmans, Willem E. Fibbe, CJ Meijer and Henriëtte M. Goselink and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

J Jansen

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Jansen Netherlands	22	834	539	497	325	272	65	1.5k
TJ Hamblin United Kingdom	14	472 0.6×	426 0.8×	364 0.7×	250 0.8×	283 1.0×	25	1.0k
J L Preud'homme France	20	809 1.0×	767 1.4×	356 0.7×	507 1.6×	505 1.9×	38	1.8k
Alexander W. Hauswirth Austria	26	928 1.1×	298 0.6×	488 1.0×	265 0.8×	353 1.3×	64	2.0k
DL Longo United States	18	603 0.7×	233 0.4×	232 0.5×	323 1.0×	256 0.9×	31	1.2k
MF Martelli Italy	15	506 0.6×	214 0.4×	405 0.8×	544 1.7×	229 0.8×	30	1.2k
R. J. Winchester United States	18	1.1k 1.3×	316 0.6×	493 1.0×	140 0.4×	415 1.5×	24	1.9k
Nobuyoshi Arima Japan	23	979 1.2×	221 0.4×	409 0.8×	157 0.5×	428 1.6×	88	1.9k
S Shane United States	13	517 0.6×	251 0.5×	409 0.8×	194 0.6×	342 1.3×	15	1.2k
Elaine J. Schattner United States	19	1.1k 1.3×	539 1.0×	211 0.4×	565 1.7×	497 1.8×	31	2.0k
Lev Shvidel Israel	23	819 1.0×	573 1.1×	244 0.5×	475 1.5×	253 0.9×	82	1.7k

Countries citing papers authored by J Jansen

Since Specialization

Citations

This map shows the geographic impact of J Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Jansen more than expected).

Fields of papers citing papers by J Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Jansen. The network helps show where J Jansen may publish in the future.

Co-authorship network of co-authors of J Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of J Jansen. A scholar is included among the top collaborators of J Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Jansen. J Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, J, et al.. (2008). Slow platelet recovery after PBPC transplantation from unrelated donors. Bone Marrow Transplantation. 43(6). 499–505. 8 indexed citations

Jansen, J, James Thompson, Michael J. Dugan, et al.. (2004). Impaired PBPC collection in patients with myeloma after high-dose melphalan. Cytotherapy. 6(5). 498–504. 9 indexed citations

List, Alan F., Richard T. Maziarz, Patrick J. Stiff, et al.. (2000). A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. Bone Marrow Transplantation. 25(3). 283–291. 20 indexed citations

Jansen, J, et al.. (1999). Hematopoietic growth factor after autologous peripheral blood transplantation: comparison of G-CSF and GM-CSF. Bone Marrow Transplantation. 23(12). 1251–1256. 12 indexed citations

Jansen, J, et al.. (1996). Immunomagnetic CD4+ and CD8+ cell depletion for patients at high risk for severe acute GVHD.. PubMed. 17(3). 377–82. 6 indexed citations

Cui, Yukun, Kevin Harvey, L Akard, et al.. (1994). Regulation of neutrophil responses by phosphotyrosine phosphatase.. The Journal of Immunology. 152(11). 5420–5428. 24 indexed citations

Jansen, J, et al.. (1992). Immunomagnetic depletion of CD8+ lymphocytes from marrow grafts.. PubMed. 377. 405–10. 1 indexed citations

Jansen, J, et al.. (1992). Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells.. The Journal of Experimental Medicine. 175(4). 1151–1154. 73 indexed citations

Champlin, Richard E., J Jansen, W. G. Ho, et al.. (1991). Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.. PubMed. 23(1 Pt 2). 1695–6. 32 indexed citations

10.

English, Denis, et al.. (1989). Semiautomated processing of bone marrow grafts for transplantation. Transfusion. 29(1). 12–16. 44 indexed citations

11.

Jansen, J, et al.. (1989). Inhibition of human macrophage colony formation by interleukin 4.. The Journal of Experimental Medicine. 170(2). 577–582. 144 indexed citations

12.

Leland, Diane S., et al.. (1989). Evaluation of four methods for cytomegalovirus antibody detection for use by a bone marrow transplantation service. Journal of Clinical Microbiology. 27(1). 176–178. 8 indexed citations

13.

Elfenbein, Gerald J., Jeffrey P. Krischer, Kenneth H. Rand, et al.. (1987). Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation.. PubMed. 19(6 Suppl 7). 138–43. 13 indexed citations

14.

Middeldorp, Jaap M., et al.. (1985). Immune reactivity in relationto cytomegalovirusinfection after allogeneic bone marrow transplantation. Transplantation Proceedings. 17. 488–488. 1 indexed citations

15.

Ottolander, G. J. den, P. Brederoo, J. P. M. Geraedts, & J Jansen. (1985). Trilineage Acute Leukaemia in Combined Ph<sup>1</sup>-Chromosome Positivity and Monosomy 7. Acta Haematologica. 73(3). 129–139. 2 indexed citations

16.

Gratama, J. W., Anneke Brand, J Jansen, et al.. (1984). Factors influencing platelet survival during antilymphocyte globulin treatment. British Journal of Haematology. 57(1). 5–15. 1 indexed citations

17.

Winkel, Chris, Henriëtte M. Goselink, W. F. J. Veenhof, F.H.J. Claas, & J Jansen. (1982). Serum inhibitors in aplastic anaemia. Annals of Hematology. 44(4). 193–200. 5 indexed citations

18.

Sabbe, L., Frans H.J. Claas, H. L. Haak, et al.. (1981). Anti-thymocyte globulin (ATG) can eliminate platelet refractoriness. Annals of Hematology. 42(6). 331–335. 6 indexed citations

19.

Tricot, Guido, F. E. Zwaan, Robert H. Kauffmann, J Jansen, & H. L. Haak. (1981). Extreme Potassium Loss in a Patient with Severe Graft Versus Host Disease. Scandinavian Journal of Haematology. 25(3). 264–267. 1 indexed citations

20.

Jansen, J, et al.. (1979). Primary Plasmacytoma of Lymph Nodes. Acta Haematologica. 61(2). 100–105. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact